[PHARMA] QoQ TTM Result on 31-Mar-2017 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-May-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Mar-2017 [#1]
Profit Trend
QoQ- 1.19%
YoY- -34.67%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 2,323,960 2,293,580 2,234,292 2,248,121 2,189,022 2,286,356 2,295,554 0.82%
PBT 73,064 57,267 61,919 73,256 72,017 91,665 97,079 -17.21%
Tax -18,077 -25,268 -21,162 -26,609 -26,158 -28,865 -26,952 -23.32%
NP 54,987 31,999 40,757 46,647 45,859 62,800 70,127 -14.93%
-
NP to SH 53,723 31,187 40,668 46,143 45,599 62,497 69,407 -15.65%
-
Tax Rate 24.74% 44.12% 34.18% 36.32% 36.32% 31.49% 27.76% -
Total Cost 2,268,973 2,261,581 2,193,535 2,201,474 2,143,163 2,223,556 2,225,427 1.29%
-
Net Worth 526,888 531,892 542,147 544,360 531,169 531,250 524,177 0.34%
Dividend
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Div 49,290 41,490 38,883 41,456 41,442 51,803 64,750 -16.58%
Div Payout % 91.75% 133.04% 95.61% 89.84% 90.88% 82.89% 93.29% -
Equity
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Net Worth 526,888 531,892 542,147 544,360 531,169 531,250 524,177 0.34%
NOSH 259,821 259,821 259,400 259,219 259,377 259,146 258,981 0.21%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 2.37% 1.40% 1.82% 2.07% 2.09% 2.75% 3.05% -
ROE 10.20% 5.86% 7.50% 8.48% 8.58% 11.76% 13.24% -
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 895.38 883.98 861.33 867.27 844.83 882.26 886.38 0.67%
EPS 20.70 12.02 15.68 17.80 17.60 24.12 26.80 -15.77%
DPS 19.00 16.00 15.00 16.00 16.00 20.00 25.00 -16.67%
NAPS 2.03 2.05 2.09 2.10 2.05 2.05 2.024 0.19%
Adjusted Per Share Value based on latest NOSH - 259,219
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 161.25 159.14 155.03 155.99 151.89 158.64 159.28 0.82%
EPS 3.73 2.16 2.82 3.20 3.16 4.34 4.82 -15.67%
DPS 3.42 2.88 2.70 2.88 2.88 3.59 4.49 -16.55%
NAPS 0.3656 0.3691 0.3762 0.3777 0.3686 0.3686 0.3637 0.34%
Price Multiplier on Financial Quarter End Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 -
Price 4.60 4.14 4.58 4.89 5.30 5.58 5.50 -
P/RPS 0.51 0.47 0.53 0.56 0.63 0.63 0.62 -12.17%
P/EPS 22.22 34.44 29.21 27.47 30.12 23.14 20.52 5.43%
EY 4.50 2.90 3.42 3.64 3.32 4.32 4.87 -5.11%
DY 4.13 3.86 3.28 3.27 3.02 3.58 4.55 -6.23%
P/NAPS 2.27 2.02 2.19 2.33 2.59 2.72 2.72 -11.32%
Price Multiplier on Announcement Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 27/02/18 15/11/17 16/08/17 16/05/17 21/02/17 21/11/16 19/08/16 -
Price 4.04 3.82 4.19 4.72 5.05 5.70 5.62 -
P/RPS 0.45 0.43 0.49 0.54 0.60 0.65 0.63 -20.04%
P/EPS 19.52 31.78 26.73 26.52 28.70 23.64 20.97 -4.65%
EY 5.12 3.15 3.74 3.77 3.48 4.23 4.77 4.82%
DY 4.70 4.19 3.58 3.39 3.17 3.51 4.45 3.70%
P/NAPS 1.99 1.86 2.00 2.25 2.46 2.78 2.78 -19.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment